The 8th annual PREDiCT: Tumour Models London Summit will return this December with a new speaker faculty to help you benchmark your oncology model selection strategy and target validation. With the rise of immuno-oncology, model requirements, target validation and the importance of tumour micro-environment are key to clinical success. The 3-days summit will provide you with real world data from a selected model experts, including Merck, MedImmune, Takeda, Roche, AstraZeneca and more for practical insights.

To learn more about 8th annual PREDiCT: Tumour Models London and to register online, visit https://ter.li/6ge5rc